Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC77H103ClN18O16 |
InChIKeySSKYEXNPDKMKLB-UHFFFAOYSA-N |
CAS Registry149716-24-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | - | - | |
Neoplasms | Phase 1 | DE | - |